Concentration among generic drugmakers may be to blame.

可能应该归罪于普通品制厂的过分集中。

AstraZeneca isn't the only drugmaker facing production delays to the EU; Pfizer-BioNTech is, too.

阿斯利康并不是唯临欧盟生产延期的制商；辉瑞和德国生新技术公司也有同样的问题。

The drugmaker AstraZeneca developed the drug.

阿斯利康制公司开发了这种。

Powerful domestic pressures are encouraging Japanese drugmakers to look abroad.

巨大的国内压力迫使日本制商将目光投向海外。

Feeling political pressure, some drugmakers have announced temporary price freezes.

感受到了政治层的压力后，些制商宣布会暂时进行价格冻结。

The FDA approved Leqembi, from Japanese drugmaker Eisai, earlier this month.

本月早些时候，美国食品品监督管理局批准了日本制商卫材业的仑卡奈单抗。

When one drugmaker has a manufacturing problem, others rarely step in.

当厂商出现了制作问题时其他厂很少介入。

After years of setbacks for RSV research, drugmakers have made big improvements this year.

呼吸道合胞病毒研究经历了多年的挫折后，制商今年取得了重大进展。

The drugmaker also agreed to end the manufacturing and distribution of opioids across the nation.

这制商还同意终止阿片类全国的生产和销售。

The Food and Drug Administration today told drugmakers to stop selling Zantac and similar heartburn medications.

食品管理局今天告知制造商停止销售善卫得和类似胃灼热的。

Dr. Glenn Begley is a bio-technology advisor and former head of cancer research at drugmaker Amgen.

格伦·贝格利博士是生技术顾问，也是制商安进公司癌症研究部门的前负责人。

But so did drugmakers, who pushed for a more serious candidate to assume the position.

制商也警醒了起来，他们推举了位标准更加严格的候选人担任负责人。

The vaccine was developed at record speed by the National Institutes of Health and by drugmaker Moderna.

这种疫苗是由美国国立卫生研究院和制商Moderna以创纪录的速度进行研发。

Another drugmaker, Eli Lilly, said it is also developing a possible treatment, donanemab, that targets the protein.

另制商礼来公司表示，它也开发种可能的治疗方法，即针对这种蛋白质的多纳单抗。

Under its bankruptcy plan the drugmaker will become a public trust and the Sackler family will relinquish ownership.

根据破产计划，这制商将成为公共信托公司，萨克勒族将放弃所有权。

The cooperation is expected to enhance the ability of the British drugmaker to discover new medicines and vaccines.

此次合作有望提高这英国制商及疫苗研发的能力。

Just yesterday, drugmaker AstraZeneca paused late-stage trials for a leading vaccine candidate when a participant developed an unexplained illness.

就昨天，制商阿斯利康暂停了种主要候选疫苗的后期试验，因为名受试者出现了种无法解释的疾病。

Back in this country, West Virginia's attorney general announced a tentative opioid settlement with two drugmakers worth $161 million.

国内方，西弗吉尼亚州总检察长宣布与两制公司就阿片类达成初步和解，价值1.61亿美元。

Drugmakers at the forefront of the covid-19-vaccine rollout are finding particular favour.

处于 covid-19 疫苗推广前沿的制商正受到特别青睐。

We now know that they're anything but low-risk-and yet drugmakers have continued to push opioids and reward doctors who prescribe them.

如今我们已经知道这种的风险丝毫不低，但企仍继续推销，继续给开处方的医生回扣。